KPTI 6.97 ▼ -1.55% Live Trading Data - Stocknear

Karyopharm Therapeutics I...

NASDAQ: KPTI · Real-Time Price · USD
6.97
-0.11 (-1.55%)
At close: Sep 04, 2025, 11:09 AM
-1.55%
Bid 5.98
Market Cap 60.44M
Revenue (ttm) 137.27M
Net Income (ttm) -123.57M
EPS (ttm) -14.84
PE Ratio (ttm) -0.47
Forward PE -0.87
Analyst Buy
Ask 7.96
Volume 13,052
Avg. Volume (20D) 164,282
Open 7.12
Previous Close 7.08
Day's Range 6.85 - 7.17
52-Week Range 3.51 - 16.95
Beta 0.28

About KPTI

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol KPTI
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for KPTI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Karyopharm Therapeutics Inc. is scheduled to release its earnings on Nov 4, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
-20%
Karyopharm Therapeutics shares are trading lower a... Unlock content with Pro Subscription
10 months ago
+17.86%
Karyopharm Therapeutics shares are trading higher after the company announced that, following the FDA feedback, it will be replacing TSS50, one of the co-primary endpoints in the Phase 3 SENTRY Trial with Abs-TSS.